Vacsera Biological Products & Vaccines Holding Company Company Profile

11:56 EDT 29th April 2016 | BioPortfolio

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,products
and services as well as our affiliated companies.

Vacsera is the leading company in the field of biological products &vaccines
manufacturing in Egypt and the Middle East.

We are focused on pursuing strategic investment opportunities in a number
of sectors within the pharmaceutical and biopharmaceutical industries.

These include research and development, manufacturing, distribution, and intellectual property acquisitions.


51 Wizaret El-Zeraa - Agouza


Phone: (202) 76 111 11
Fax: (202) 33 698 72

News Articles [2772 Associated News Articles listed on BioPortfolio]

Tianjin Tasly Starts $784 Million China Healthcare Fund

Tianjin Tasly Holding Group and Taikang Life Insurance Company have launched a $784 million China healthcare fund. The fund will invest in hospitals, medical equipment, diagnostics, nutritional produc...

Chemical engineers have figured out how to make vaccines faster

(Brigham Young University) Researchers at Brigham Young University have devised a system to speed up the process of making life-saving vaccines for new viruses.Their concept is to create the biologica...

FDA Offers Free, Continuing Education Course to Help Health Care Providers Understand ‘Biosimilars’

By: Leah Christl, Ph.D. You may have heard about a new category of products called “biosimilars.” What are biosimilars and how do they relate to biological products already widely in use? Biologic...

BRIEF-Tiantan Biological Products' shares to halt trading from Feb 19 pending announcement

Feb 18 (Reuters) - Beijing Tiantan Biological Products Corp Ltd

Webinar will explore the differences between biological and biosimilar medicines

The Royal Pharmaceutical Society is holding a live webinar to look at the differences between biological medicines and biosimilars

GSK sees rise in sales of vaccines, healthcare products

Pharmaceutical company GlaxoSmithKline says higher sales of vaccines and consumer healthcare products pushed up its earnings from core business by 19 percent in the first quarter.

Vaccines and biologics driving Charles River investments

Demand for biological products has driven recent investments in vaccine manufacturing and cell banking, says Charles River Laboratories.

NBTY, Inc. and Alphabet Holding Company, Inc. to Webcast Year End Conference Call

RONKONKOMA, N.Y., Nov. 16, 2015 /PRNewswire/ -- NBTY, Inc. ("NBTY") and Alphabet Holding Company, Inc. ("Holdings") today announced that they will webcast a joint conference call to review their ...

PubMed Articles [2661 Associated PubMed Articles listed on BioPortfolio]

Bringing plant-based veterinary vaccines to market: Managing regulatory and commercial hurdles.

The production of recombinant vaccines in plants may help to reduce the burden of veterinary diseases, which cause major economic losses and in some cases can affect human health. While there is abund...

3(RD) ESCMID conference on vaccines in Lisbon, Portugal: Vaccines for mutual protection.

Comparison of Current Regulatory Status for Gene-Based Vaccines in the U.S., Europe and Japan.

Gene-based vaccines as typified by plasmid DNA vaccines and recombinant viral-vectored vaccines are expected as promising solutions against infectious diseases for which no effective prophylactic vacc...

Estimation of Nickel in Different Smokeless Tobacco Products and Their Impact on Human Health of Oral Cancer Patients.

It has been extensively investigated that the chewing of smokeless tobacco (SLT) products may enhance the inflammation of the oral cavity. The aim of the present study is to evaluate the relationship ...

Microneedle Arrays Delivery of the Conventional Vaccines Based on Non-virulent Viruses.

Recently, microneedle arrays (MAs) have been developed for painless inoculation of vaccines and possess many prominent advantages, including convenience for inoculation, and exact delivery of vaccine ...

Clinical Trials [2302 Associated Clinical Trials listed on BioPortfolio]

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

The Holding Area LINQ Trial is a clinical trial designed to compare the benefits in conducting impant procedures in the holding area of a hospital operating room vs cardiac catheterization...

A Study to Test the Safety of Three Experimental HIV Vaccines

The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the ...

Prevention of Radiation Pneumonitis After Three-Dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-Small-Cell Lung Cancer

The purpose of this study is to evaluate the interest of breath holding for the prevention of radiation pneumonitis following conformal radiation therapy. Eligible patients will be random...

Companies [1584 Associated Companies listed on BioPortfolio]

Vacsera Biological Products & Vaccines Holding Company

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,productsand services as well as our affiliated companies.Va...

Biological E Limited

Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...

Embrex Incorporated

Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity andprofitability of the global poultry industry. Embrex has developed and commerci...


ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system includi...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...

More Information about "Vacsera Biological Products & Vaccines Holding Company" on BioPortfolio

We have published hundreds of Vacsera Biological Products & Vaccines Holding Company news stories on BioPortfolio along with dozens of Vacsera Biological Products & Vaccines Holding Company Clinical Trials and PubMed Articles about Vacsera Biological Products & Vaccines Holding Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vacsera Biological Products & Vaccines Holding Company Companies in our database. You can also find out about relevant Vacsera Biological Products & Vaccines Holding Company Drugs and Medications on this site too.

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record